Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety
Author： Beck Michael
Publisher： Informa Healthcare
ISSN： 1471-2598
Source： Expert Opinion on Biological Therapy, Vol.9, Iss.2, 2009-02, pp. : 255-261
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
